The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer

Support Line: 0300 373 8500

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Studying long-term data for Venetoclax in people who were previously taking the drug on other trials

Main Aims

This study is open to people who were given the drug Venetoclax on a previous trial, ensuring they can still access it until a point that the drug stops working for them. This helps researchers understand how the drug works long term in patients.

Recruitment Criteria

• You received Venetoclax in a previous study and continue to have a benefit from the drug

Recruitment status: Not Recruiting

Sponsor: Abbvie

Expected to end: 01/02/2026

Phases: Phase 3

Regions: East Midlands, London, North West England, South East England, South West England, West Midlands

The UK charity for Waldenstrom’s Macroglobulinaemia

WMUK, Foden House, 47 London Road,
Alderley Edge, Cheshire, SK9 7JT

Registered as a charity in England and Wales (1187121).

A company limited by guarantee in England and Wales (12358324).

Privacy & Cookies

Support Line: 0300 373 8500

General enquiries: 0300 303 5870